Regiospecific Synthesis of Mono-N-substituted Indolopyrrolocarbazoles
作者:Wolfgang Fröhner、Barbara Monse、Tobias M. Braxmeier、Laura Casiraghi、Heidi Sahagún、Pierfausto Seneci
DOI:10.1021/ol051550a
日期:2005.10.1
Two complementary and efficient strategies have been developed for the regiospecific synthesis of unsymmetrical indolopyrrolocarbazoles (IPCs) mono-N-substituted with a pentacycle. A halogen in position 2 of the intermediate bisindolylmaleimides 3a-e allows a selective Mitsunobu coupling by exploiting the increased acidity of the 2-chloro-substituted indole nitrogen. It also promotes an easier cyclization of bisindolylmaleimides 4a-e and 7b-e to IPCs. Alkylation of the 2-unsubstituted indole-3-carboxamides 2a,b and further processing to the corresponding IPCs gives access to the opposite regioisomers.
BERGMAN J.; CARLSON R.; SJOEBERG B., J. HETEROCYCL. CHEM. <JHTC-AD>, 1977, 14, NO 7, 1123-1134
作者:BERGMAN J.、 CARLSON R.、 SJOEBERG B.
DOI:——
日期:——
US7262215B2
申请人:——
公开号:US7262215B2
公开(公告)日:2007-08-28
[EN] N-CARBACYCLE MONOSUBSTITUTED INDOLOCARBAZOLES AS PROTEIN KINASE INHIBITORS<br/>[FR] INDOLOCARBAZOLES MONOSUBSTITUES A N-CARBACYCLES UTILISES COMME INHIBITEURS DE PROTEINE-KINASE
申请人:NAD AG
公开号:WO2003051887A1
公开(公告)日:2003-06-26
This invention relates to N-carbacycle monosubstituted indolocarbazole compounds. Furthermore, this invention relates to medicaments comprising N-carbacycle monosubstituted indolocarbazoles compounds and the use of such compounds for treating non-insulin dependent diabetes mellitus, acute stroke and other neurotraumatic injuries, for treating diabetes mellitus, as a chemotherapeutic for the treatment of various malignant diseases, for treating diseases caused by malfunctioning of specific signaling pathways, and for treating neurodegenerative diseases such as for example Alzheimer's disease.